All News #Library
Generics
Remicade® ( Infliximab): Janssen Biotech V. Celltrion Healthcare & Hospira
31 May 2017 //
PATENT LITIGATION
Remicade® (Infliximab): Janssen Biotech, Inc. V. Samsung Bioepis Co., Ltd.
17 May 2017 //
PATENT LITIGATION
USPTO Files Response Brief in In re Janssen Biotech, Inc. & New York University
15 May 2017 //
PRESS RELEASE

Market Place
Sourcing Support